Clustering analysis for omalizumab responder patient profiles identification. Fenoma study

C. Almonacid Sánchez (Madrid, Spain), J. Soto Campos (Jerez de la Frontera, Cádiz, Spain), P. Campo Mozo (Málaga, Spain), A. Moreira Jorge (Barcelona, Spain), I. Davila Gonzalez (Salamanca, Spain)

Source: International Congress 2018 – Asthma management
Session: Asthma management
Session type: Poster Discussion
Number: 1689
Disease area: Airway diseases

Congress or journal article abstractSlide presentationE-posterWebcast

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Almonacid Sánchez (Madrid, Spain), J. Soto Campos (Jerez de la Frontera, Cádiz, Spain), P. Campo Mozo (Málaga, Spain), A. Moreira Jorge (Barcelona, Spain), I. Davila Gonzalez (Salamanca, Spain). Clustering analysis for omalizumab responder patient profiles identification. Fenoma study. 1689

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: